INS and Hyperglycemia: Disease progression is potentiated by a reduced capacity of β-cells to undergo metabolic compensation, leading to additional β-cell stress and dysfunction due to hyperglycemia, a process culminating in a requirement for insulin replacement therapies (Kahn et al., 2014).